default author photo

Andrea Bocobo

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

18

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer

Number of pages: 36 Posted: 14 Jan 2026
affiliation not provided to SSRN, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, affiliation not provided to SSRN, University of California, San Francisco (UCSF), University of Pennsylvania, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of California, San Francisco (UCSF), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Pennsylvania, University of California, San Francisco (UCSF) - Departments of Otolaryngology-Head and Neck Surgery and of Microbiology and Immunology, University of California, San Francisco (UCSF) and affiliation not provided to SSRN
Downloads 18 (1,470,786)

Abstract:

Loading...

mismatch repair-proficient, microsatellite stable, CRC, Pembrolizumab, chemotherapy, capecitabine, Bevacizumab